Ceftizoxime
From Wikipedia, the free encyclopedia
 |
This article needs additional citations for verification. (April 2013) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
| Clinical data | |
| Trade names | Cefizox |
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a684043 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 68401-81-0 68401-82-1 |
| ATC code | J01DD07 |
| PubChem | CID 6533629 |
| ChemSpider | 5018818 |
| UNII | C43C467DPE  |
| KEGG | D07658 |
| ChEMBL | CHEMBL528 |
| Chemical data | |
| Formula | C13H13N5O5S2 |
| Mol. mass | 383.405 g/mol |
Ceftizoxime is a third-generation cephalosporin available for parenteral administration. Unlike other 3rd generation cephalosporins, in ceftizoxime the whole C-3 side chain has been removed to prevent deactivation by hydrolytic enzymes. It rather resembles cefotaxime in its properties, but is not subjected to metabolism.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
